Combining education & technology with compassion & concern to provide the highest quality care for all patients with macular and vitreoretinal disease.

Font Size:

Office Treatments

Intravitreal injections:
Avastin, Lucentis, Eylea, Kenalog, and Jetrea
are all intravitreal (injected into the back of the eye) injections. These injections are the most used medical procedures in the United States. It's the best form of treatment for Exudative (Wet) AMD, Diabetic Retinopathy, Retinal vein/artery occlusions, choroidal neovascular membrane secondary to many retinal conditions.
    Avastin, Lucentis, and Eylea are all "Anti-VEGF" medications. VEGF or Vascular Endothelial Growth Factor is what makes new blood vessels (neovascularization) grow that aren't suppose to be there. These intravitreal injections are to stop or slow the process down.
    Kenalog is a steroid injection used to treat macular edema. Conditions such as diabetes, uveitis, and vein occlusions can cause swelling in the macula (the center of the retina responsible for your pinpoint vision). If the swelling does not go down from steroid drops your doctor may use Kenalog to help treat the swelling.
    Jetrea is used for Vitreomacular traction / adhesion. Vitreomacular traction is where the gel in the back of your eye is pulling on the macula (center of retina) which can cause distortion in your central vision. Once Jetrea is injected it causes the gel to release from the macula thus improving the central vision.

Barrier, Pan Retinal Photocoagulation, and Focal Laser: The Pascal laser system provides a unique method that controls laser delivery in four ways, enable greated precision and control at the tissue level. With the Pascal system we can help treat Retinal tears with the Barrier laser. For proliferative diabetic retinopathy we can help manage the new blood vessel growth by using the Pan Retinal Photocoagulation method. Also able to laser more focalized areas with the Focal laser method for isolated incidences.

Pneumatic Retinopexy is an effective in-office procedure for certain types of retinal detachments. It uses a bubble of gas to push the retina against the wall of the eye, allowing fluid to be pumped out from beneath the retina. It is usually an outpatient procedure done with local anesthesia. During pneumatic retinopexy, the eye doctor (ophthalmologist) injects a gas bubble into the middle of the eyeball. Your head is positioned so that the gas bubble floats to the detached area and presses lightly against the detachment. The bubble flattens the retina so that the fluid can be pumped out from beneath it. The eye doctor then uses a freezing probe (cryopexy) or laser beam (photocoagulation) to seal the tear in the retina. The bubble remains for about 1 to 3 weeks to help flatten the retina, until a seal forms between the retina and the wall of the eye. The eye gradually absorbs the gas bubble.

Endophthalmitis Management: Endophthalmitis is an inflammation of the internal coats of the eye. It is a possible complication of all intraocular surgeries, particularly cataract surgery, with possible loss of vision and the eye itself. Infectious etiology is the most common and various bacteria and fungi have been isolated as the cause of the endophthalmitis. Other causes include penetrating trauma and retained intraocular foreign bodies.

The patient needs urgent examination by an ophthalmologist and/or vitreo-retina specialist who will usually decide for urgent intervention to provide intravitreal injection of potent antibiotics and also prepare for an urgent pars plana vitrectomy as needed. In severe cases enucleation may be required to remove a blind and painful eye.